Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):74-81. doi: 10.1111/jdv.15819. Epub 2019 Aug 23.
Determining whether repigmentation within or adjacent to lentigo maligna or lentigo maligna melanoma (LM/LMM) scars represents recurrence of melanoma is challenging. The use of reflectance confocal microscopy (RCM) and dermoscopy may aid in differentiating true melanoma recurrence from other causes of repigmentation.
To describe the characteristics of repigmentation within or adjacent to LM/LMM scars observable on RCM and dermoscopy.
We retrospectively analysed patients who presented with new pigmentation within or adjacent to scars from surgically treated LM/LMM between January 2014 and December 2018. Clinical and demographic characteristics and time to recurrence were recorded. RCM was used to evaluate areas of pigmentation before biopsy. If available, dermoscopic images were also evaluated.
In total, 30 confocal studies in 29 patients were included in the study cohort. Twenty-one patients had biopsy-confirmed recurrent LM/LMM; the remainder had pigmented actinic keratosis (n = 4) or hyperpigmentation/solar lentigo (n = 5). RCM had sensitivity of 95.24% (95% CI, 76.18-99.88%), specificity of 77.7% (95% CI, 39.99-97.19%), positive predictive value of 90.91% (95% CI, 74.58-97.15%) and negative predictive value of 87.5% (95% CI, 50.04-98.0%). The most common dermoscopic feature observed among patients with recurrent LM/LMM was focal homogeneous or structureless areas of light-brown pigmentation (92.8% vs. 37.5% in patients with other diagnoses; P = 0.009). LM-specific dermoscopic criteria were present in only 28.5% of patients with recurrent LM/LMM.
Reflectance confocal microscopy and dermoscopy are valuable tools for the comprehensive evaluation of repigmentation within or adjacent to LM scars.
确定是否在恶性雀斑样痣或恶性雀斑样黑素瘤(LM/LMM)瘢痕内或附近的复色代表黑素瘤的复发,这具有挑战性。使用反射式共聚焦显微镜(RCM)和皮肤镜检查可能有助于区分真正的黑素瘤复发与其他复色原因。
描述在 LM/LMM 瘢痕内或附近通过 RCM 和皮肤镜检查观察到的复色特征。
我们回顾性分析了 2014 年 1 月至 2018 年 12 月期间因手术治疗 LM/LMM 而出现瘢痕内或附近新色素沉着的患者。记录临床和人口统计学特征以及复发时间。在活检前使用 RCM 评估色素沉着区域。如果有,也评估皮肤镜图像。
共纳入 29 例患者的 30 项共聚焦研究。21 例患者经活检证实为 LM/LMM 复发;其余 4 例为色素性光化性角化病,5 例为色素性日光性雀斑样痣或色素性单纯性雀斑样痣。RCM 的敏感性为 95.24%(95%CI,76.18%99.88%),特异性为 77.7%(95%CI,39.99%97.19%),阳性预测值为 90.91%(95%CI,74.58%97.15%),阴性预测值为 87.5%(95%CI,50.04%98.0%)。在 LM/LMM 复发患者中最常见的皮肤镜特征是局灶性均匀或无结构的浅棕色色素沉着(92.8% vs. 37.5%,在其他诊断患者中;P=0.009)。仅 28.5%的 LM/LMM 复发患者存在 LM 特异性皮肤镜标准。
反射式共聚焦显微镜和皮肤镜检查是评估 LM 瘢痕内或附近复色的综合评估的有价值的工具。